Clinical trial Recruiting at 12 sites Phase 4 Interventional Ages 18 to 80

Inhaled isoflurane versus IV propofol for sedation of ventilated ICU patients

Official title: Inhaled Sedation in Critically Ill Patients: a Multicentre Randomized Clinical Trial

Run by Instituto de Investigación Hospital Universitario La Paz · NCT07000526 · Data updated 2026-11-12

This trial will test whether inhaled isoflurane delivered through the Sedaconda ACD‑S shortens time on the ventilator compared with intravenous propofol in adults needing deep sedation and expected to require mechanical ventilation for more than 48 hours.

More Sedation trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment620 (estimated)
SponsorInstituto de Investigación Hospital Universitario La Paz
Academic / other
Locations22 sites (Orihuela, Alicante and 21 other locations)
StatusRecruiting
StartedDecember 15, 2025
Main results expectedMarch 2027
Study endsDecember 2027
Registry record updatedJune 29, 2026
Trial IDNCT07000526 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults on invasive mechanical ventilation who require deep sedation (RASS -3 to -5), are expected to need ventilation for more than 48 hours, and have no contraindications to isoflurane or propofol are the intended participants.

Probably not a fit

Patients with contraindications to either drug, those already ventilated for more than 48 hours, patients on ECMO or ECCO2R, pregnant or breastfeeding individuals, or those with acute neurological conditions or severe respiratory derangements are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, phase 4 trial assigns adult ICU patients 1:1 to inhaled isoflurane via the Sedaconda ACD‑S device or to standard intravenous propofol for deep sedation. The primary outcome is ventilator-free days at 28 days after randomization, with key secondary outcomes including ICU-free days, time to extubation after sedation withdrawal, and adequacy of sedation. Eligible patients are adults on invasive mechanical ventilation expected to need more than 48 hours of ventilation with a target RASS between -3 and -5 and without contraindications such as ECMO, pregnancy, or severe respiratory derangements. The trial emphasizes longer sedation periods to address gaps left by earlier short-duration studies of inhaled ICU sedation.

Why it matters

Potential benefit: If successful, inhaled isoflurane could reduce duration of mechanical ventilation and ICU stay, lowering complication risk and speeding patient recovery.

How similar studies have gone: Prior short-duration ICU studies have shown isoflurane to be non-inferior to propofol and have suggested it may facilitate weaning, but long-term outcomes after prolonged inhaled sedation remain largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Adult patients receiving mechanical ventilation, with an anticipated duration \>48 hours after randomization, and requiring deep sedation (target RASS between -3 and -5).

Exclusion Criteria:

* Contraindication to isoflurane or propofol
* Patients with maternal ancestry from Venezuela, due to the potential presence of an mt-ND4 gene mutation associated with neurological injury after exposure to certain volatile anaesthetic agents
* Significant air leak, defined as a leak exceeding 30% of the delivered minute ventilation
* Allergy to isoflurane or propofol
* Cardiopulmonary arrest
* History of ventricular tachycardia or long QT syndrome
* Tidal volume \< 300 mL or PaCO₂ \> 50 mmHg at the time of randomization.
* Invasive mechanical ventilation for more than 48 hours at the time of randomization.
* Pregnancy
* Breast feeding
* Acute neurological condition
* Patients expected to require repeated surgical interventions during their ICU stay.
* ECMO
* ECCO2R
* Active humidification strictly required
* Neuromuscular disease or high spinal cord injury likely to prevent discontinuation of mechanical ventilation due to baseline condition
* Requirement for benzodiazepine use for a specific indication
* Burns
* Life expectancy less than 48 hours, or patients with such a level of severity that death during the ICU stay is considered highly likely.
* Any condition (e.g., blindness, deafness, dementia) or language barrier that prevents the administration of delirium or cognitive assessment scales.
* Lack of informed consent

Where it's running

  • Hospital Vega Baja
    Orihuela, Alicante, Spain
    Recruiting
  • Hospital Germans Trias i Pujol
    Badalona, Spain
    Recruiting
  • Hospital Universitario de Bellvitge
    Barcelona, Spain
    Recruiting
  • Hospital Universitario Valle de Hebron
    Barcelona, Spain
    Recruiting
  • Hospital Universitario La Paz
    Madrid, Spain
    Recruiting
  • Hospital Universitario de la Princesa
    Madrid, Spain
    Recruiting
Show 16 more locations
  • Hospital Universitario Gregorio Marañon
    Madrid, Spain
    Recruiting
  • Hospital Universitario Infanta Leonor
    Madrid, Spain
    Recruiting
  • Hospital Universitario Rey Juan Carlos
    Madrid, Spain
    Recruiting
  • Hospital Universitario Joan XXIII
    Tarragona, Spain
    Recruiting
  • Hospital Clínico Universitario de Valencia
    Valencia, Spain
    Recruiting
  • Hospital Universitario Rio Hortega
    Valladolid, Spain
    Recruiting
  • Hospital Universitario Doctor José Molina Orosa
    Arrecife, Lanzarote-Canary Islands, Spain
    Not yet recruiting
  • Hospital Galdakao-Usansolo Ospitalea
    Galdakao, Vizcaya, Spain
    Not yet recruiting
  • Hospital Universitario de Albacete
    Albacete, Spain
    Not yet recruiting
  • Hospital Universitario de Jaen
    Jaén, Spain
    Not yet recruiting
  • Hospital Arnau de Vilanova
    Lleida, Spain
    Not yet recruiting
  • Hospital Universitario de Fuenlabrada
    Madrid, Spain
    Not yet recruiting
  • Hospital Universitario Ramon y Cajal
    Madrid, Spain
    Not yet recruiting
  • Hospital Univeritario Puerta de Hierro
    Madrid, Spain
    Not yet recruiting
  • Hospital Regional Universitario de Málaga
    Málaga, Spain
    Not yet recruiting
  • Hospital Universitario de Toledo
    Toledo, Spain
    Not yet recruiting

Study contacts

  • Principal investigator: José M. Añón, MD, PhD — Hospital Universitario La Paz. IdiPAZ
  • Study coordinator: José M. Añón, MD, PhD
  • Email: jmaelizalde@gmail.com
  • Phone: +(34) 912071307

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.